Quest Diagnostics (DGX) Income from Continuing Operations: 2009-2024
Historic Income from Continuing Operations for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $902.0 million.
- Quest Diagnostics' Income from Continuing Operations rose 8.66% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 13.59%. This contributed to the annual value of $902.0 million for FY2024, which is 2.27% up from last year.
- Latest data reveals that Quest Diagnostics reported Income from Continuing Operations of $902.0 million as of FY2024, which was up 2.27% from $882.0 million recorded in FY2023.
- Over the past 5 years, Quest Diagnostics' Income from Continuing Operations peaked at $2.0 billion during FY2021, and registered a low of $882.0 million during FY2023.
- In the last 3 years, Quest Diagnostics' Income from Continuing Operations had a median value of $902.0 million in 2024 and averaged $918.3 million.
- Per our database at Business Quant, Quest Diagnostics' Income from Continuing Operations skyrocketed by 71.77% in 2020 and then tumbled by 51.50% in 2022.
- Over the past 5 years, Quest Diagnostics' Income from Continuing Operations (Yearly) stood at $1.4 billion in 2020, then spiked by 40.59% to $2.0 billion in 2021, then tumbled by 51.50% to $971.0 million in 2022, then fell by 9.17% to $882.0 million in 2023, then increased by 2.27% to $902.0 million in 2024.